Prevalence and determinants of valvulopathy in patients treated with dexfenfluramine

Prevalence and determinants of valvulopathy in patients treated with dexfenfluramine

Item
http://www.wikidata.org/entity/Q28376858
Risk of valvular heart disease associated with use of fenfluramineAppetite suppressants and valvular heart disease - a systematic review.Insulin resistance and beta-cell dysfunction as therapeutic targets in type 2 diabetes.Developmental basis for filamin-A-associated myxomatous mitral valve disease.The metabolic syndrome in China.Safety of drug therapies used for weight loss and treatment of obesity.Role of serotoninergic pathways in drug-induced valvular heart disease and diagnostic features by echocardiographyFenfluramine disrupts the mitral valve interstitial cell response to serotonin.Risk of valvular heart disease associated with the use of dopamine agonists in Parkinson's disease: a systematic review.Reverse translation of adverse event reports paves the way for de-risking preclinical off-targets.Cardiovascular safety of low-dose fenfluramine in Dravet syndrome: a review of its benefit-risk profile in a new patient population.Effects of lorcaserin on pre-existing valvulopathy: A pooled analysis of phase 3 trials.Diet medications and valvular heart disease: the current evidence.Aortic valvular regurgitation: prevalence and clinical characteristics in a predominantly obese adult population not taking anorexigens.Response to the letter by AcarEstimate of deaths due to valvular insufficiency attributable to the use of benfluorex in FrancePathological Conditions Associated with the Disturbance of the 5-HT System
P2860

Prevalence and determinants of valvulopathy in patients treated with dexfenfluramine

Item
http://www.wikidata.org/entity/Q28376858
description
1999 nî lūn-bûn
@nan
1999 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Prevalence and determinants of valvulopathy in patients treated with dexfenfluramine
@ast
Prevalence and determinants of valvulopathy in patients treated with dexfenfluramine
@en
Prevalence and determinants of valvulopathy in patients treated with dexfenfluramine
@nl
type
label
Prevalence and determinants of valvulopathy in patients treated with dexfenfluramine
@ast
Prevalence and determinants of valvulopathy in patients treated with dexfenfluramine
@en
Prevalence and determinants of valvulopathy in patients treated with dexfenfluramine
@nl
prefLabel
Prevalence and determinants of valvulopathy in patients treated with dexfenfluramine
@ast
Prevalence and determinants of valvulopathy in patients treated with dexfenfluramine
@en
Prevalence and determinants of valvulopathy in patients treated with dexfenfluramine
@nl
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P356
P1433
P1476
Prevalence and determinants of valvulopathy in patients treated with dexfenfluramine
@en
P2093
P304
P31
P356
10.1161/01.CIR.100.21.2161
P407
P433
P478
P577
P5875
P698